IC
PFE icon

Inscription Capital’s Pfizer PFE Stock Holding History

Inscription Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$761K Sell
31,586
-11,768
-27% -$308K 0.07% 270
2026
Q1 		$1.22M Sell
43,354
-8,108
-16% -$216K 0.13% 146
2025
Q4 		$1.28M Buy
51,462
+1,216
+2% +$30.7K 0.13% 138
2025
Q3 		$1.28M Buy
50,246
+28,946
+136% +$714K 0.14% 132
2025
Q2 		$516K Sell
21,300
-16,884
-44% -$394K 0.07% 198
2025
Q1 		$1.06M Buy
+38,184
New +$999K 0.17% 97
2024
Q3 		$926K Sell
32,013
-4,383
-12% -$128K 0.14% 117
2024
Q2 		$1.02M Sell
36,396
-1,788
-5% -$49.2K 0.16% 102
2024
Q1 		$1.06M Buy
38,184
+21,875
+134% +$607K 0.17% 97
2023
Q4 		$470K Buy
16,309
+1,914
+13% +$57.9K 0.13% 123
2023
Q3 		$477K Sell
14,395
-938
-6% -$33.2K 0.16% 103
2023
Q2 		$562K Buy
15,333
+135
+0.9% +$5.25K 0.17% 94
2023
Q1 		$620K Sell
15,198
-4,744
-24% -$205K 0.16% 102
2022
Q4 		$1.02M Buy
19,942
+300
+2% +$14.4K 0.35% 66
2022
Q3 		$860K Sell
19,642
-24,844
-56% -$1.21M 0.24% 72
2022
Q2 		$2.33M Buy
44,486
+25,334
+132% +$1.29M 0.42% 53
2022
Q1 		$992K Sell
19,152
-200
-1% -$10.4K 0.28% 75
2021
Q4 		$1.14M Buy
19,352
+7,910
+69% +$392K 0.31% 73
2021
Q3 		$492K Sell
11,442
-402,135
-97% -$17.8M 0.15% 124
2021
Q2 		$16.2M Buy
413,577
+401,991
+3,470% +$15.6M 1.84% 10
2021
Q1 		$420K Buy
11,586
+3,907
+51% +$139K 0.14% 124
2020
Q4 		$283K Sell
7,679
-145
-2% -$5.32K 0.11% 141
2020
Q3 		$272K Buy
+7,824
New +$274K 0.12% 130
2020
Q2 		– Sell
-6,875
Closed -$213K – 145
2020
Q1 		$213K Buy
+6,875
New +$234K 0.14% 114
2019
Q2 		– Sell
-1,054
Closed -$42K – 205
2019
Q1 		$42K Buy
+1,054
New +$42.2K 0.02% 195

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Inscription Capital's PFE Position: Q2 2026 in Review

Inscription Capital reduced its Pfizer (PFE) stake by 27% in Q2 2026, selling an estimated $308K and leaving 31,586 shares worth $761K. The position accounts for 0.07% of the portfolio, ranked #270.

Inscription Capital first reported a position in PFE in Q1 2019 and has held it in 25 quarters since. The position peaked at $16.2M in Q2 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Inscription Capital held 31,586 shares of Pfizer worth $761K as of Q2 2026.
  • Inscription Capital sold 11,768 Pfizer shares in Q2 2026, an estimated $308K.
  • Pfizer made up 0.07% of Inscription Capital's portfolio in Q2 2026, its #270 holding.
  • Inscription Capital first reported a position in Pfizer in Q1 2019 and has held it in 25 quarters since.
  • Inscription Capital's Pfizer position peaked at $16.2M in Q2 2021.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.